- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00034619
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
July 18, 2006 updated by: Eli Lilly and Company
The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancer
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Huntsville, Alabama, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Massachusetts
-
Pittsfield, Massachusetts, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Michigan
-
Kalamazoo, Michigan, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
New York
-
Latham, New York, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
North Carolina
-
Asheville, North Carolina, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Goldsboro, North Carolina, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Hendersonville, North Carolina, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Winston-Salem, North Carolina, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Ohio
-
Columbus, Ohio, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Oregon
-
Bend, Oregon, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Portland, Oregon, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Pittsburgh, Pennsylvania, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Reading, Pennsylvania, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
South Carolina
-
Charleston, South Carolina, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Utah
-
Ivins, Utah, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Ogden, Utah, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Provo, Utah, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
St. George, Utah, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Washington
-
Bellevue, Washington, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Seattle, Washington, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
Spokane, Washington, United States
- "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of primary cancer of the colon or rectum
- Must have measurable disease
- Must be able to comply with study procedure
Exclusion Criteria:
- Prior chemotherapy for advanced disease
- Pregnancy or lactation
- Candidates for surgical resection of one or more metastatic foci
- Second primary cancer
- Inability to take folic acid or vitamin B12
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
May 1, 2002
First Submitted That Met QC Criteria
May 1, 2002
First Posted (Estimate)
May 2, 2002
Study Record Updates
Last Update Posted (Estimate)
July 19, 2006
Last Update Submitted That Met QC Criteria
July 18, 2006
Last Verified
July 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5142
- H3E-MC-JMEP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Oxaliplatin
-
Xijing HospitalUnknownGastrointestinal CancerChina
-
Lin ChenUnknownGastric AdenocarcinomaChina
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Chonnam National University... and other collaboratorsCompletedColorectal CancerKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceSuspended
-
University of ChicagoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States